Home › Funds › Sarasin & Partners LLP › CME

Sarasin & Partners LLP position in CME

CME GROUP INC · Financials

Sarasin & Partners LLP reported holding 1,320,960 shares of CME (CME GROUP INC) in its Q3 2026 13F filing — a position valued at US$346.1M, representing 3.88% of its reported portfolio and ranking #7 among its reported holdings. Sarasin & Partners LLP has disclosed CME holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.32M sh
Reported value held$346.07M
Portfolio Weight3.88%
First reportedQ3 2023
Last changeAdd
Updated2026-10-15

Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR

How Sarasin & Partners LLP's CME position evolved

Sarasin & Partners LLP first disclosed a stake in CME in Q3 2023 at 2,487,141 shares (US$498.0M). Across 13 filings, Sarasin & Partners LLP increased the stake 4 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,320,960 shares valued at US$346.1M — an increase of 6,692 shares quarter over quarter.. Notable position changes include a 32% trim in Q1 2025 (shares rose 4% over the following quarter), a 41% increase in Q2 2026 (shares rose 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.49M $497.98M New
Q4 2023 2.25M $474.69M Reduce
Q1 2024 2.28M $491.78M Add
Q2 2024 2.00M $393.53M Reduce
Q3 2024 1.76M $387.38M Reduce
Q4 2024 1.74M $403.08M Reduce
Q1 2025 1.17M $311.08M Reduce
Q2 2025 1.01M $279.72M Reduce
Q3 2025 1.13M $306.34M Add
Q4 2025 1.09M $298.46M Reduce
Q1 2026 930.69K $274.88M Reduce
Q2 2026 1.31M $290.23M Add
Q3 2026 1.32M $346.07M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CME and 13F data

CME (CME GROUP INC) is a Financials company. 27 other funds we track also report a position in CME — the largest reported positions include Banque Cantonale Vaudoise (US$3.33B), Sanders Capital, LLC (US$1.12B), RAYMOND JAMES FINANCIAL INC (US$896.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CME

All CME fund holders →

FAQ

How long has Sarasin & Partners LLP held CME?

Sarasin & Partners LLP has disclosed CME holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Sarasin & Partners LLP's current position in CME?

As of Q3 2026, Sarasin & Partners LLP holds 1.32M shares of CME (CME GROUP INC), valued at $346.07M, representing 3.88% of its reported portfolio and ranking #7.

Has Sarasin & Partners LLP been buying or selling CME?

In the latest 13F filing (Q3 2026), Sarasin & Partners LLP increased its position in CME.

Which other funds hold CME?

Other major institutional holders of CME include Banque Cantonale Vaudoise, Sanders Capital, LLC, RAYMOND JAMES FINANCIAL INC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.